Moxifloxacine Eg (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacine Eg, is a fluoroquinolone presented as an oral tablet for systemic use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, and exacerbations of chronic bronchitis in adult patients, and is also indicated for skin and soft‑tissue infections and intra‑abdominal infections.

GNH USA supplies Moxifloxacine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing full traceability from manufacturing to delivery.

Moxifloxacin is a fluoroquinolone antibacterial used to treat several common bacterial infections. - Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbation of chronic bronchitis: controls bacterial load and alleviates cough. - Skin and skin structure infections: eliminates skin‑associated bacteria and promotes healing. - Intra‑abdominal infections: targets mixed bacterial flora to resolve abdominal infection.

Moxifloxacin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile colitis: severe diarrhea with abdominal pain. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing moxifloxacin, clinicians should consider several safety measures. - Assess renal function: adjust therapy if significant impairment exists. - Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. - Check cardiac status: avoid in patients with known QT‑prolongation risk. - Avoid use in patients with known hypersensitivity to fluoroquinolones. - Store at room temperature: keep in the original pack, protect from moisture and light.

Moxifloxacin can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce moxifloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Other QT‑prolonging drugs: heightened risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: may increase central nervous system side effects. - Corticosteroids: may raise the risk of tendon rupture. - CYP450 inhibitors (e.g., fluconazole): may elevate moxifloxacin plasma concentrations.